3P Biopharmaceuticals_Betalutin

3P Biopharmaceuticals and Nordic Nanovector have extended partnership for Betalutin® late stage manufacturing for B-cell non-Hodgkin lymphoma (NHL) treatment

Wednesday June 26th, 2019 | General

3P Biopharmaceuticals (3P) and Norwegian biopharmaceutical company Nordic Nanovector have extended their collaboration agreement for the biopharmaceutical development of Betalutin® late stage manufacturing for B-cell non-Hodgkin lymphoma (NHL) treatment. The non-Hodgkin lymphoma (NHL) is cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system. 3P and Nordic Nanovector started their […]

3P Biopharmaceuticals enters into manufacturing agreement with the Swedish company Affibody

Thursday June 6th, 2019 | General

The arrangement covers process transfer, process development and GMP manufacture of Affibody’s candidate 3P Biopharmaceuticals, a leading CDMO specialized in the process development and GMP manufacturing of biologics, has signed a collaboration agreement with the Swedish company Affibody for the process transfer, scale-up and GMP commercial manufacturing of a recombinant protein sole property of Affibody. […]

Large-scale manufacturing process for Strangvac now secured

Tuesday April 2nd, 2019 | General

We are so glad to be part of such an exciting project with the Swedish company INTERVACC, who we are working with on manufacturing of Strangvac® including the large-scale production of the vaccine against equine strangles. The biotechnology company Intervacc has together with 3P Biopharmaceuticals, the contracted manufacturer of Strangvac, secured large-scale production of the […]

3P Biopharmaceuticals enters into a new manufacturing agreement with the Dutch Biotech Company Xenikos

Monday March 11th, 2019 | General

Pamplona, 11th of March, 2019. 3P Biopharmaceuticals, a leading CDMO specialized in the process development and GMP manufacturing of biologics, has signed a collaboration agreement with the Dutch biotech company Xenikos B. V. (Xenikos) that will cover the global manufacturing of Xenikos’ proprietary lead product candidate T-Guard®. 3P and Xenikos started their collaboration in 2015 […]

Expansion of analytical capacities by 3P Biopharmaceuticals

Wednesday February 27th, 2019 | General

3P Biopharmaceuticals has recently increased its analytical capacities and capabilities.   The 3P Analytical Development Area is one of the company’s core competences and is crucial to the state-of-the-art technologies as well as services it provides to the clients.   The development of analytical methods is an essential activity in any process development and manufacturing […]

Merry Christmas and Happy New Year 2019!

Tuesday December 18th, 2018 | General

Our entire team wishes you a Merry Christmas and our Warm Wishes for a wonderful Holiday Season. Our very best wishes for a happy new year filled with health, happiness, and spectacular success!

Welcome to our new website

Tuesday December 11th, 2018 | General

We are pleased to announce the launch of our newly revamped website which creates a user-friendly browsing experience. The new structure provides a more interactive experience, allowing our partners to easily find the information they are looking for. In addition to aesthetically re-designing our website, we have also refined our services category structure to provide […]

3P Biopharmaceuticals successfully completes the expansion and improvement of its facilities

Wednesday December 5th, 2018 | General

3P has implemented a new design in its manufacturing plant increasing its capacities and incorporating innovative equipment and state of the art technologies. The investments made in infrastructure and equipment during 2018 exceed 5 million euros. 3P Biopharmaceuticals has successfully completed the project for the expansion and improvement of its facilities in Noáin (Spain) that […]

Permanent award in the form of the Reconcilia Label

Tuesday December 4th, 2018 | General

Permanent award in the form of the Reconcilia Label. We are proud to have received a permanent award in the form of the Reconcilia Label. Last 27th November, the AMEDNA (Navarre Business Women´s Association) recognized those companies that are engaged in the reconciliation of professional, family and personal life. We have obtained the permanent recognition […]

Annual bioProcessUK Conference 2018

Monday November 12th, 2018 | Events, General

Meet us at the Annual bioProcessUK Conference 2018! The BIA is organizing the 15th Annual bioProcessUK Conference that is taking place in Edinburgh on 20-22 November 2018. The conference goes from strength to strength and 2017 saw over 285 delegates from 160 leading organisations attend to hear the latest news/updates and developments within the manufacturing […]